DOI:
10.1055/s-00039252
Revista Argentina de Radiología / Argentinian Journal of Radiology
LinksClose Window
References
O′Brien MF, Cronin AM, Fearn PA, Smith B, Stasi J, Guillonneau B. et al.
Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy.
J Clin Oncol. 2009;
27 (22) 3591-3597
We do not assume any responsibility for the contents of the web pages of other providers.